Thorac Cardiovasc Surg 2009; 57(1): 50-52
DOI: 10.1055/s-2008-1038407
Short Communications

© Georg Thieme Verlag KG Stuttgart · New York

Surgical Considerations on the Use of the Percutaneous Ventricular Assist Device TandemHeart® in Critical Aortic Valve Stenosis

M. Loebe1 , W. H. Zade Asfahani1 , G. P. Petrov1 , N. S. Kleiman1 , G. Torre-Amione1
  • 1Methodist DeBakey Heart Center, Houston, Texas, United States
Further Information

Publication History

Received November 6, 2007

Publication Date:
23 January 2009 (online)

Abbreviations

AS aortic stenosis

AVR aortic valve replacement

PCI percutaneous coronary intervention

LV left ventricle

pLVAD percutaneous left ventricular assist device

IABP intra-aortic balloon pump counterpulsation

AICD automatic implantable cardioverter defibrillator

LVEF left ventricular ejection fraction

References

  • 1 Carabello B A. Clinical practice. Aortic stenosis.  N Engl J Med. 2002;  346 677-682
  • 2 Botkin N F, Aurigemma G P. Aortic valve disease: current recommendations.  Curr Cardiol Rep. 2004;  6 89-95
  • 3 Schwarz F, Baumann P, Manthey J. et al . The effect of aortic valve replacement on survival.  Circulation. 1982;  66 1105-1110
  • 4 Vaquette B, Corbineau H, Laurent M. et al . Valve replacement in patients with critical aortic stenosis and depressed left ventricular function: predictors of operative risk, left ventricular function recovery, and long term outcome.  Heart. 2005;  91 1324-1329
  • 5 Vranckx P, Foley D P, de Feijter P J. et al . Clinical introduction of the TandemHeart®, a percutaneous left ventricular assist device, for circulatory support during high-risk percutaneous coronary intervention.  Int J Cardiovasc Intervent. 2003;  5 35-39
  • 6 Loebe M, Potapov E, Sodian R, Kopitz M, Noon G P. A safe and simple method of preserving right ventricular function during implantation of a left ventricular assist device.  J Thorac Cardiovasc Surg. 2001;  122 1043
  • 7 Frank C M, Palanichamy N, Kar B. et al . Use of a percutaneous ventricular assist device for treatment of cardiogenic shock due to critical aortic stenosis.  Tex Heart Inst J. 2006;  33 487-489

MD, PhD Matthias Loebe

Methodist DeBakey Heart Center

6560 Fannin #1860

Houston, TX 77030

United States

Email: mloebe@bcm.tmc.edu